Single-dose Toxicity of Water-soluble Ginseng Pharmacopuncture Injected Intramuscularly in Rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Radix Ginseng has been traditionally used as an adaptogen that acts on the adrenal cortex and stimulates or relaxes the nervous system to restore emotional and physical balance and to improve well-being in cases of degenerative disease and/or old age. Radix Ginseng has been used for a long time, but the safety of ginseng pharmacopuncture needs testing. This study was done to analyze the single-dose toxicity of water- soluble ginseng pharmacopuncture (GP) intramuscular injections in rats. Methods: All experiments were performed at Biotoxtech, an institution authorized to perform non clinical studies under the regulations of Good Laboratory Practice (GLP). Each group contained 10 Sprague-Dawley rats, 5 males and 5 females. GP was prepared in a sterile room at the Korean Pharmacopuncture Institute under regulations of Good Manufacturing Practice (GMP). GP dosages were 0.1, 0.5 and 1.0 mL for the experimental groups; normal saline was administered to the control group. The animals general condition was examined daily for 14 days, and the rats were weighed on the starting day and at 3, 7 and 14 days after administration of the pharmacopuncture. Hematological and biochemis biochemistry tests and autopsies were done to test the toxicological effect of GP after 14 days. This study was performed with approval from the Institutional Animal Ethics Committee of Biotextech. Results: No deaths were found in this single-dose toxicity test of intramuscular injections of GP, and no significant changes in the general conditions, body weights, hematological and biochemistry tests, and autopsies were observed. The local injection site showed no changes. Based on these results, the lethal dose was assumed to be over 1.0 mL/animal in both sexes. Conclusion: These results suggest that GP is relatively safe. Further studies, including a repeated toxicity test, are needed to provide more concrete evidence for the safety of GP.
Abstract
Objectives: Radix Ginseng has been traditionally used as an adaptogen that acts on the adrenal cortex and stimulates or relaxes the nervous system to restore emotional and physical balance and to improve well-being in cases of degenerative disease and/or old age. Radix Ginseng has been used for a long time, but the safety of ginseng pharmacopuncture needs testing. This study was done to analyze the single-dose toxicity of water- soluble ginseng pharmacopuncture (GP) intramuscular injections in rats. Methods: All experiments were performed at Biotoxtech, an institution authorized to perform non clinical studies under the regulations of Good Laboratory Practice (GLP). Each group contained 10 Sprague-Dawley rats, 5 males and 5 females. GP was prepared in a sterile room at the Korean Pharmacopuncture Institute under regulations of Good Manufacturing Practice (GMP). GP dosages were 0.1, 0.5 and 1.0 mL for the experimental groups; normal saline was administered to the control group. The animals general condition was examined daily for 14 days, and the rats were weighed on the starting day and at 3, 7 and 14 days after administration of the pharmacopuncture. Hematological and biochemis biochemistry tests and autopsies were done to test the toxicological effect of GP after 14 days. This study was performed with approval from the Institutional Animal Ethics Committee of Biotextech. Results: No deaths were found in this single-dose toxicity test of intramuscular injections of GP, and no significant changes in the general conditions, body weights, hematological and biochemistry tests, and autopsies were observed. The local injection site showed no changes. Based on these results, the lethal dose was assumed to be over 1.0 mL/animal in both sexes. Conclusion: These results suggest that GP is relatively safe. Further studies, including a repeated toxicity test, are needed to provide more concrete evidence for the safety of GP.
참고문헌 (16)
- 김정대, "A Descriptive Statistical Approach to the Korean Pharmacopuncture Therapy", Journal of Acupuncture & Meridian Studies, 3(3), pp.141~149 (2010), 사단법인약침학회
- Kang BS, "Translated into Korean. big dictionary of traditional Chinese medicine", pp.4484~ (1997), Jungdam Publishing Co
- An IS, "Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells", Oncol Rep, 29(2), pp.523~528 (2012)
- Kim AD, "Ginseng saponin metabolite induces apoptosis in MCF-7 breast cancer cells through the modulation of AMP-activated protein kinase", Environ Toxicol Phar, 30(2), pp.134~140 (2010)
- Yuan HD, "20(S)-ginsenoside Rg3-induced apoptosis in HT-29 colon cancer cells is associated with AMPK signaling pathway", Mol Med Rep, 3(5), pp.825~831 (2010)
- Pan XY, "Ginsenoside Rg3 attenuates cell migration via inhibition of aquaporin 1 expression in PC-3M prostate cancer cells", Eur J Pharmacol, 683(1-3), pp.27~34 (2012)
- Tanaka O, "Saponins of ginseng and related plants", Fortschr Chem Org Naturst, 46, pp.1~76 (1984)
- 정희선, "인삼·산양삼·자연산 산삼의 ginsenoside 함량 분석 및 홍삼화 후의 변화 관찰", Journal of Pharmacopuncture, 13(1), pp.63~77 (2010), 대한약침학회
- 한영주, "인삼과 산양삼, 산삼의 HPLC를 이용한 부위별 성분 분석 비교", Journal of Pharmacopuncture, 10(1), pp.37~53 (2007), 대한약침학회
- Kim KH, "Target genes involved in antiproliferative effect of modified ginseng extracts in lung cancer A549 cells", Acta Biochim Biophys Sin, 46(6), pp.441~449 (2014)
- Hwang JW, "An enzymatically fortified ginswng extract inhibits proliferation and induces apoptosis of KATO3 human gastric cancer cells via modulation of BAX, mTOR, PKB, and IkBa", Mol Med Rep, 11(1), pp.670~676 (2015)
- Dasgupta A, "Effect of Asian and Siberian ginseng on serum digoxin measurement by five digoxin immunoassays", Am J Clin Pathol, 119(2), pp.298~303 (2003)
- Sung WS, "In vitro candidacidal action of Korean red ginseng saponins against candidaalbicans(microbiology)", Biol Pharm Bull, 31(1), pp.139~142 (2008)
- Lee B, "Inhibitory effects of ginseng total saponins on behavioral sensitization and dopamine release induced by cocaine", Biol Pharm Bull, 31(3), pp.436~441 (2008)
- Wang W, "Experiment therapy of prostate cancer with novel natural product anti-cancer ginsenosides", Prostate, 68(8), pp.809~819 (2008)
- Fiona M, "A-Z of complementary and alternative medicine: a guide for health professionals", pp.137~138 (2009), Churchill Livingstone